Privacy settings

We use cookies on our website. Some of them are essential, while others help us improve this website and your experience.

We take good care of you and your data. You can read more about how we use cookies and update your cookie settings here.

Group	Essential
Name	Contao HTTPS CSRF Token
Technical name	csrf_https-contao_csrf_token
Provider
Expire in days	0
Privacy policy
Use	Used to protect the encrypted website (HTTPS) from forgery of cross-site requests. After closing the browser the cookie is deleted again
Allowed
Name	PHP SESSION ID
Technical name	PHPSESSID
Provider
Expire in days	0
Privacy policy
Use	Cookie from PHP (programming language), PHP data identifier. Contains only a reference to the current session. No information is stored in the user's browser and this cookie can only be used by the current website. This cookie is mainly used in forms to increase the user experience. Data entered in forms is stored for a short time, for example, if there is an input error by the user and the user receives an error message. Otherwise, all data would have to be entered again. Translated with www.DeepL.com/Translator (free version)
Allowed
Group	Analysis
Name	Matomo
Technical name	_pk_ses.2.7a1c,_pk_id.2.7a1c
Provider	Matomo
Expire in days	72
Privacy policy
Use	Matomo Tracking
Allowed

Publication

Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia

Nicola Gökbuget, Gerhard Zugmaier, Matthias Klinger, Peter Kufer, Matthias Stelljes, Andreas Viardot, Heinz A. Horst, Svenja Neumann, Monika Brüggemann, Oliver G. Ottmann, Thomas Burmeister, Dorothea Wessiepe, Max S. Topp, Ralf Bargou

https://www.haematologica.org/article/view/8049

Source

Vol. 102 No. 4 (2017): April, 2017 https://doi.org/10.3324/haematol.2016.153957

Whitepaper and Publications overview